Drug developers have designed therapies to reduce the cholesterol-carrying molecule Lp(a), which is associated with heart ...
A study from the Institute of Nutrition and Translational Research in Metabolism (NUTRIM) at Maastricht University Medical ...
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule ...
Kaila Charles had to contain her hype. The play wasn’t over. Atlanta guard Allisha Gray had charged up the court in transition, looking to attack early. Only Valkyries point guard Veronica Burton ...
The pages of a paper book do not emit light themselves. They reflect the light in the room to deliver the text to your eyes.
Natural products produced by microorganisms are a promising source of new drugs. Researchers at the Helmholtz Center for ...
Corxel Pharmaceuticals will list on Nasdaq via Amanat Acquisition Corp in a deal targeting $377M. Read how this ...
Morning Overview on MSN
Researchers imaged how atorvastatin holds open a muscle calcium channel, a proposed reason statins leave some people with aching muscles
Three molecules of the cholesterol drug atorvastatin can sit together in a single pocket of a calcium channel in muscle cells ...
Despite promising results in smaller trials, nicotinamide riboside fails to slow the progression of early Parkinson’s disease ...
The transaction was announced publicly in this press release. James Schneider, John Rearick, Andrea Reid, Mark Jones and ...
From molecular design to trial recruitment, artificial intelligence is influencing the choices behind drug development.
Phase 1b study evaluating safety, tolerability, pharmacokinetics and target engagement of the gut-selective candidate; topline data expected by end of 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results